| Financial Year |
March 31 2023 |
| Monetary Funds |
19,094,439.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
143,382,975.74 |
| Advances to Suppliers |
38,209,271.89 |
| Other Receivables |
8,463,848.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
24,381,919.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,995,379.06 |
| Total Current Assets |
246,527,834.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
200,949,381.64 |
| Investment Properties |
-- |
| Fixed Assetes |
50,267,782.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,428,842.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
95,744.95 |
| Deferred Income Tax Assets |
40,961,208.33 |
| Other Non-Current Assets |
150,000.00 |
| Sub-Total of Non-Current Assets |
366,988,573.92 |
| Total Assets |
613,516,408.47 |
| Short-Term Loans |
56,977,793.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
54,074,045.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,499,797.97 |
| Taxes Payable |
819,608.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
140,583,962.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,635,917.41 |
| Other Current Liabilities |
608,987.67 |
| Sub-Total of Current Liabilities |
265,597,223.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,715.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,194,983.11 |
| Total Liabilities |
274,792,206.79 |
| Paid-In Capital(Or Share Stock) |
93,338,000.00 |
| Capital Surplus |
66,182,644.11 |
| Surplus Reserve |
46,669,000.00 |
| LESS:Treasury Stock |
16,273,285.98 |
| Undistributed Profits |
145,659,294.24 |
| Minority Stockholder's Interest |
3,388,392.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
335,335,809.05 |
| Owner's Equity（Stockholder's Equity） |
338,724,201.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
613,516,408.47 |
